BG103502A - Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists - Google Patents
Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonistsInfo
- Publication number
- BG103502A BG103502A BG103502A BG10350299A BG103502A BG 103502 A BG103502 A BG 103502A BG 103502 A BG103502 A BG 103502A BG 10350299 A BG10350299 A BG 10350299A BG 103502 A BG103502 A BG 103502A
- Authority
- BG
- Bulgaria
- Prior art keywords
- preparation
- application
- carboxylic acids
- receptor antagonists
- heterocyclic derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C07D237/16—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/18—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
- C07D253/10—Condensed 1,2,4-triazines; Hydrogenated condensed 1,2,4-triazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE1996152763 DE19652763A1 (de) | 1996-12-18 | 1996-12-18 | Heterozyklische Carbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| DE1997100884 DE19700884A1 (de) | 1997-01-13 | 1997-01-13 | Heterozyklische Carbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| PCT/EP1997/006778 WO1998027070A1 (de) | 1996-12-18 | 1997-12-04 | Heterozyklische carbonsäurederivate, ihre herstellung und verwendung als endothelinrezeptorantagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103502A true BG103502A (en) | 2000-07-31 |
Family
ID=26032394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103502A BG103502A (en) | 1996-12-18 | 1999-06-18 | Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6448248B1 (es) |
| EP (1) | EP0946524A1 (es) |
| JP (1) | JP2001506243A (es) |
| KR (1) | KR20000057642A (es) |
| CN (1) | CN1247533A (es) |
| AR (1) | AR010359A1 (es) |
| AU (1) | AU740351B2 (es) |
| BG (1) | BG103502A (es) |
| BR (1) | BR9714047A (es) |
| CA (1) | CA2275256A1 (es) |
| CO (1) | CO4930270A1 (es) |
| HR (1) | HRP970686A2 (es) |
| HU (1) | HUP0000553A3 (es) |
| ID (1) | ID26234A (es) |
| IL (1) | IL130251A0 (es) |
| NO (1) | NO313519B1 (es) |
| NZ (1) | NZ336157A (es) |
| PL (1) | PL334014A1 (es) |
| SK (1) | SK77799A3 (es) |
| TR (1) | TR199901416T2 (es) |
| WO (1) | WO1998027070A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ299741B6 (cs) | 1997-09-26 | 2008-11-05 | Abbott Gmbh & Co. Kg | Kombinace endotelinového antagonisty a RAS inhibitoru a její použití, farmaceutický prostredek s jejím obsahem a zpusob výroby tohoto prostredku |
| DE19743143A1 (de) | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
| DE69830069T3 (de) * | 1997-10-17 | 2012-02-09 | Ark Therapeutics Ltd. | Verwendung von hemmern des renin-angiotensin systems zur behandlung von hypoxie oder verringertem stoffwechsel |
| DE19806438A1 (de) * | 1998-02-17 | 1999-08-19 | Basf Ag | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| DE19858779A1 (de) * | 1998-12-18 | 2000-06-21 | Basf Ag | Neue ß-Amido und ß-Sulfonamidocarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| EP1239877B1 (en) * | 1999-10-06 | 2008-01-09 | Abbott GmbH & Co. KG | Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| FI20010233A0 (fi) * | 2001-02-08 | 2001-02-08 | Orion Corp | Menetelmä sydämen vajaatoiminnan hoitoon |
| WO2003006041A1 (fr) * | 2001-07-12 | 2003-01-23 | Takeda Chemical Industries, Ltd. | Agents prophylactiques/therapeutiques contre les tumeurs malignes |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2671551B1 (fr) * | 1991-01-15 | 1993-03-12 | Adir | Nouveaux composes de structure aryl triazinique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19614542A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19614534A1 (de) | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19614533A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung |
-
1997
- 1997-12-04 US US09/319,876 patent/US6448248B1/en not_active Expired - Fee Related
- 1997-12-04 WO PCT/EP1997/006778 patent/WO1998027070A1/de not_active Application Discontinuation
- 1997-12-04 EP EP97952876A patent/EP0946524A1/de not_active Withdrawn
- 1997-12-04 SK SK777-99A patent/SK77799A3/sk unknown
- 1997-12-04 PL PL97334014A patent/PL334014A1/xx unknown
- 1997-12-04 IL IL13025197A patent/IL130251A0/xx unknown
- 1997-12-04 CN CN97181869A patent/CN1247533A/zh active Pending
- 1997-12-04 AU AU56594/98A patent/AU740351B2/en not_active Ceased
- 1997-12-04 JP JP52724798A patent/JP2001506243A/ja active Pending
- 1997-12-04 ID IDW990558A patent/ID26234A/id unknown
- 1997-12-04 TR TR1999/01416T patent/TR199901416T2/xx unknown
- 1997-12-04 HU HU0000553A patent/HUP0000553A3/hu unknown
- 1997-12-04 CA CA002275256A patent/CA2275256A1/en not_active Abandoned
- 1997-12-04 KR KR1019990705445A patent/KR20000057642A/ko not_active Application Discontinuation
- 1997-12-04 BR BR9714047-3A patent/BR9714047A/pt not_active IP Right Cessation
- 1997-12-04 NZ NZ336157A patent/NZ336157A/xx unknown
- 1997-12-16 AR ARP970105907A patent/AR010359A1/es not_active Application Discontinuation
- 1997-12-16 HR HR19700884.4A patent/HRP970686A2/hr not_active Application Discontinuation
- 1997-12-17 CO CO97073662A patent/CO4930270A1/es unknown
-
1999
- 1999-06-17 NO NO19992976A patent/NO313519B1/no not_active IP Right Cessation
- 1999-06-18 BG BG103502A patent/BG103502A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR199901416T2 (xx) | 1999-08-23 |
| ID26234A (id) | 2000-12-07 |
| BR9714047A (pt) | 2000-05-09 |
| AU740351B2 (en) | 2001-11-01 |
| JP2001506243A (ja) | 2001-05-15 |
| US6448248B1 (en) | 2002-09-10 |
| IL130251A0 (en) | 2000-06-01 |
| HUP0000553A3 (en) | 2001-08-28 |
| NO992976L (no) | 1999-06-17 |
| NZ336157A (en) | 2000-10-27 |
| CO4930270A1 (es) | 2000-06-27 |
| EP0946524A1 (de) | 1999-10-06 |
| PL334014A1 (en) | 2000-01-31 |
| AU5659498A (en) | 1998-07-15 |
| WO1998027070A1 (de) | 1998-06-25 |
| KR20000057642A (ko) | 2000-09-25 |
| AR010359A1 (es) | 2000-06-07 |
| CN1247533A (zh) | 2000-03-15 |
| HUP0000553A1 (hu) | 2001-04-28 |
| CA2275256A1 (en) | 1998-06-25 |
| NO313519B1 (no) | 2002-10-14 |
| NO992976D0 (no) | 1999-06-17 |
| SK77799A3 (en) | 2000-02-14 |
| HRP970686A2 (en) | 1998-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200101398T2 (tr) | Pirolidin türevleri-CCR-3 reseptörü antagonistleri. | |
| BG103251A (en) | Oxydiazols, methods for their preparation and application as medicamentous forms | |
| MX9702070A (es) | Nuevos inhibidores de resorcion osea y antagonistas de receptor de vitronectina. | |
| BG104831A (en) | Heterocyclically substituted amides, their production and their use | |
| PL331998A1 (en) | Derivatives of azinyloxy-a nd phenyloxy-diaryl carboxylic acids, their production and application as mixed antagonists of endothelin et/et receptors | |
| CZ29296A3 (en) | Substituted biphenylsulfonamide derivatives as endothelial antagonists | |
| BG103502A (en) | Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists | |
| HU9503089D0 (en) | Use of indole derivatives as 5ht1 antagonists | |
| BG105847A (en) | Calcilytic compounds | |
| BG102770A (en) | New derivatives of carboxylic acids, their preparation and application | |
| MY120550A (en) | Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions. | |
| BG104291A (en) | 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use | |
| PL330708A1 (en) | Derivatives of indolydine useful as antagonists of 5-ht-2c receptor | |
| BG104022A (en) | New beta-amino and beta-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists | |
| MX9603199A (es) | Antagonistas de receptores a endotelina. | |
| PL333079A1 (en) | Piparazinic derivatives as antagonists of neurokinin | |
| MX9603045A (es) | Antagonistas de los receptores endoteliales. | |
| TR200001080T2 (tr) | 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri | |
| BG104222A (en) | Novel carboxylic acid derivatives, their production and their use as mixed eta/etb endothelin-receptor antagonists | |
| HUT77174A (hu) | Heterociklusos csoporttal szubsztituált 3-(indol-3-il)-akrilsav-származékok, mint NMDA antagonisták, és a vegyületeket tartalmazó gyógyszerkészítmények | |
| DE69526738D1 (de) | Endothelin-rezeptor-antagonisten | |
| BG105618A (en) | Beta-amido and beta-sulphonamide derivatives of carboxylic acids, method for preparation and application as endothelin-receptor antagonists | |
| BG106154A (en) | Carboxylic acid derivatives comprising aryl-substituted nitrogen heterocycles, methods for their production and their use as endothelin receptor antagonists | |
| IL137038A0 (en) | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists | |
| BG106321A (en) | Novel carboxylic acid derivatives with 5,6- substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |